Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The median time-to-onset of gastrointestinal AEs was 1 (IQR 024) days, and 77.44% of the AEs occurred within 30 days after excluding invalid reports
openPR disclaims liability for any content contained in this release
It works by mimicking the activity of the GLP-1 and GIP hormones naturally secreted in the intestines after eating
A clear, colorless solution indicates proper storage
CJC 1295 Ipamorelin is a peptide therapy that combines two peptides CJC 1295 and Ipamorelin: CJC 1295 is a growth hormone-releasing hormone (GHRH) Ipamorelin is a growth hormone secretagogue (GHS) Together, they work synergistically to increase the production and release of growth hormone in the body
US$ 27.07
US$ 23.65
US$ 23.68
US$ 27.69
US$ 29.59
